PortalPublikationenReal-time liquid biopsy

Real-time liquid biopsy

Standard

Real-time liquid biopsy : circulating tumor cells versus circulating tumor DNA. / Alix-Panabières, Catherine; Pantel, Klaus.

in: J TRANSL MED, Jahrgang 1, Nr. 2, 07.2013, S. 18.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Alix-Panabières, C & Pantel, K 2013, 'Real-time liquid biopsy: circulating tumor cells versus circulating tumor DNA', J TRANSL MED, Jg. 1, Nr. 2, S. 18. https://doi.org/10.3978/j.issn.2305-5839.2013.06.02

APA

Alix-Panabières, C., & Pantel, K. (2013). Real-time liquid biopsy: circulating tumor cells versus circulating tumor DNA. J TRANSL MED, 1(2), 18. https://doi.org/10.3978/j.issn.2305-5839.2013.06.02

Vancouver

Alix-Panabières C, Pantel K. Real-time liquid biopsy: circulating tumor cells versus circulating tumor DNA. J TRANSL MED. 2013 Jul;1(2):18. https://doi.org/10.3978/j.issn.2305-5839.2013.06.02

Bibtex

@article{88533da5ac694cc6ae6a937403254ab2,
title = "Real-time liquid biopsy: circulating tumor cells versus circulating tumor DNA",
abstract = "Liquid biopsy is a new diagnostic concept, i.e., analysis of therapeutic targets and drug resistance-conferring gene mutations on circulating tumor cells and cell-free circulating tumor DNA released into the peripheral blood from metastatic deposits. Here, we discuss current challenges and future perspectives of the liquid biopsy concept in clinical oncology. We postulate that this concept will contribute to a better understanding and clinical management of drug resistance in cancer patients.",
author = "Catherine Alix-Panabi{\`e}res and Klaus Pantel",
year = "2013",
month = jul,
doi = "10.3978/j.issn.2305-5839.2013.06.02",
language = "English",
volume = "1",
pages = "18",
journal = "J TRANSL MED",
issn = "1479-5876",
publisher = "BioMed Central Ltd.",
number = "2",

}

RIS

TY - JOUR

T1 - Real-time liquid biopsy

T2 - circulating tumor cells versus circulating tumor DNA

AU - Alix-Panabières, Catherine

AU - Pantel, Klaus

PY - 2013/7

Y1 - 2013/7

N2 - Liquid biopsy is a new diagnostic concept, i.e., analysis of therapeutic targets and drug resistance-conferring gene mutations on circulating tumor cells and cell-free circulating tumor DNA released into the peripheral blood from metastatic deposits. Here, we discuss current challenges and future perspectives of the liquid biopsy concept in clinical oncology. We postulate that this concept will contribute to a better understanding and clinical management of drug resistance in cancer patients.

AB - Liquid biopsy is a new diagnostic concept, i.e., analysis of therapeutic targets and drug resistance-conferring gene mutations on circulating tumor cells and cell-free circulating tumor DNA released into the peripheral blood from metastatic deposits. Here, we discuss current challenges and future perspectives of the liquid biopsy concept in clinical oncology. We postulate that this concept will contribute to a better understanding and clinical management of drug resistance in cancer patients.

U2 - 10.3978/j.issn.2305-5839.2013.06.02

DO - 10.3978/j.issn.2305-5839.2013.06.02

M3 - SCORING: Journal article

C2 - 25332962

VL - 1

SP - 18

JO - J TRANSL MED

JF - J TRANSL MED

SN - 1479-5876

IS - 2

ER -